Open Orphan’s hVIVO launches its Disease in Motion platform

Team experience Small dedicated team of Senior Medical Writers and Clinical Trial Assistant with total team experience in clinical and regulatory writing of more than 75 years In addition, Venn is working with a flexible shell

IntroductionAn international biotech company, headquartered in the EU approached hVIVO to explore the possibility of performing a RSV Phase IIa challenge study. The investigational product was a novel recombinant modified vaccinia virus Ankara RSV vaccine candidate.

Candidate exhibits a novel mechanism of action and differs considerably from previously approved drugs Open Orphan – a specialists in testing infectious and respiratory disease products using human challenge clinical trials – has announced that its

A growing specialist contract organization, hVIVO—a subsidiary of Open Orphan plc—has been tapped by Cocrystal Pharma to conduct a phase 2a clinical trial of its novel broad-spectrum, orally administered antiviral candidate, CC-42344. Housed in hVIVO’s state-of-the-art

Gene therapy offers significant potential to treat diseases with high unmet medical need. However, the unique nature of these therapies poses challenges in product development, namely: safety concerns, efficacy issues, or obstacles related to Chemistry, Manufacturing and Controls

FluCamp is all about improving the health of the population, through increasing understanding around common viral illnesses. Ultimately, the more that we understand about how viruses affect the human immune system, the more quickly we can

In the early months of the pandemic, human challenge clinical trials drew amplified public interest on its potential to accelerate the hunt for Covid-19 vaccines. Fast forward two years later, while mainstream media buzz around this trial

Allergic rhinitis or, as it is commonly known, hay fever, is a reaction to allergens in the air. Most commonly this is a reaction to the pollen count, but can also be to dust, mould or

In your 20’s life tends to change dramatically – and it can be easy to let your health take a back seat. However, it is a period in which is vital to establish a healthy lifestyle,

For 20+ years, members of the CMC (Chemistry Manufacturing and Control) team have supported and are supporting numerous pharmaceutical companies to ensure the timely development and manufacture of high-quality drug substances and drug products for non-clinical-

The COVID pandemic started at the turn of 2020. The virus was first detected in Wuhan, China and since then has spread around the globe and mutated into several different strains. As of June 2022, the

Hvivo will enrol healthy volunteers to test the efficacy of a biotech company’s oral vaccine candidate for Covid-19. A subsidiary of Dublin-based pharma services company Open Orphan said it is developing the world’s first human challenge

The winter season can wreak havoc on your immune system, particularly when we spend much of our time huddled indoors, and our diet may become a little more carbohydrate based. Fortunately, science has allowed us to

The flu jab has encountered some controversy during its time in circulation. However, recent research suggests that some of these rumoured negative effects may in fact not be true – and actually, the opposite might apply.

For 20+ years, members of the CMC (Chemistry, Manufacturing and Controls) team supported numerous (bio)pharmaceutical and biotechnological companies to ensure the development and manufacture of high-quality drug substances and drug products for » CMC management and